Mortality from overdose among injecting drug users recently released from prison: database linkage study.
OBJECTIVE
To assess whether injecting drug users have a higher than usual risk of death from overdose in the 2 weeks after release from prison.


METHODS
Soundex coding of surnames and information on date of birth were used to link entry and release dates from the local prison between 1983 and 1994 with clinical data from Edinburgh City Hospital's cohort of male injecting drug users who are infected with HIV.


METHODS
Edinburgh City Hospital and Edinburgh Prison.


METHODS
316/332 male injecting drug users infected with HIV in the City Hospital HIV cohort; 16 were excluded because they were enrolled after developing AIDS or because their precise date of death was not available.


METHODS
Relative risk of dying from overdose before developing AIDS and relative risk of dying of all causes before developing AIDS during the 2 weeks after release from prison; this was compared with relative risks of death during other time at liberty.


RESULTS
238/316 (75%) injecting drug users served time in the prison between 1983 and 1994. 33 out of 316 injecting drug users who were infected with HIV died before developing AIDS during 517,177 days at risk. 20 of these men died of an overdose; 6 of these deaths occurred within 2 weeks of release during 5903 days at risk. Death rates from overdose before the development of AIDS were 1.02/1000 days during the 2 weeks after release (recently released) and 0.029/1000 days during other times of liberty. The relative risk of death from overdose became 7.7 (1.5 to 39.1) after temporal matching (when the comparison was limited to the first 2 weeks after release v the next 10 weeks). The crude relative risk in an analysis combining stratified prison term and the 2 weeks after release was 4.5 (1.7 to 11.7) for death from overdose. After temporal matching these risks became 1.8 (0.4 to 9.2).


CONCLUSIONS
Prisons should evaluate interventions to reduce the risk of death from overdose after release.
Seaman
S R
SR
Medical Research Council Biostatistics Unit, Institute of Public Health, Cambridge.
Brettle
R P
RP
Gore
S M
SM
D000163:Acquired Immunodeficiency Syndrome / Q000401:mortality; D015331:Cohort Studies; D062787:Drug Overdose / Q000401:mortality; D015658:HIV Infections / Q000401:mortality; D006801:Humans; D008297:Male; D011329:Prisoners / Q000706:statistics & numerical data; D012307:Risk Factors; D012606:Scotland / Q000453:epidemiology; D015819:Substance Abuse, Intravenous / Q000401:mortality*